Orion Pharma Limited (DSE:ORIONPHARM)

Orion Pharma Ratios and Metrics

Market cap in millions BDT. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 16, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	7,207	16,169	18,626	20,592	12,613	9,828
Market Cap Growth	-52.39%	-13.19%	-9.54%	63.27%	28.33%	26.51%
Enterprise Value	31,871	39,765	42,351	40,514	28,904	23,780
Last Close Price	30.80	67.36	76.63	83.74	50.68	38.57
PE Ratio	-	50.83	29.06	24.34	13.43	14.76
PS Ratio	0.98	1.52	1.34	2.13	1.16	1.29
PB Ratio	0.32	0.70	0.83	0.99	0.63	0.51
P/TBV Ratio	0.34	0.75	0.89	1.07	0.68	0.55
P/FCF Ratio	-	-	-	-	-	29.00
P/OCF Ratio	3.68	10.19	7.47	17.73	4.87	5.22
EV/Sales Ratio	4.32	3.74	3.04	4.19	2.67	3.11
EV/EBITDA Ratio	31.57	26.51	26.91	35.29	11.43	9.66
EV/EBIT Ratio	47.34	42.80	42.65	60.01	18.79	15.32
EV/FCF Ratio	-425.28	-	-	-	-	70.17
Debt / Equity Ratio	1.03	0.98	0.98	0.90	0.84	0.72
Debt / EBITDA Ratio	23.31	14.83	13.74	15.87	6.59	5.51
Debt / FCF Ratio	-	-	-	-	-	40.50
Asset Turnover	0.14	0.20	0.28	0.21	0.27	0.23
Inventory Turnover	3.08	5.04	7.12	5.01	6.10	4.62
Quick Ratio	1.71	1.82	1.64	1.59	2.14	2.86
Current Ratio	1.99	2.17	2.01	1.99	2.70	3.99
Return on Equity (ROE)	-0.19%	1.55%	3.22%	4.36%	5.73%	3.89%
Return on Assets (ROA)	0.76%	1.09%	1.23%	0.93%	2.43%	2.86%
Return on Capital (ROIC)	0.92%	1.29%	1.48%	1.11%	2.75%	3.21%
Return on Capital Employed (ROCE)	1.50%	2.00%	2.30%	1.70%	4.20%	4.80%
Earnings Yield	-22.19%	1.97%	3.44%	4.11%	7.45%	6.77%
FCF Yield	-103.98%	-1.79%	-7.33%	-7.31%	-13.36%	3.45%
Dividend Yield	322.58%	1.48%	1.31%	1.19%	2.37%	2.59%
Payout Ratio	-	84.84%	23.86%	38.36%	36.22%	56.04%
Total Shareholder Return	322.58%	1.48%	1.31%	1.19%	2.37%	2.59%

Updated Feb 1, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.